Surojit Paul

5.0k total citations · 2 hit papers
39 papers, 4.0k citations indexed

About

Surojit Paul is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Surojit Paul has authored 39 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 11 papers in Neurology. Recurrent topics in Surojit Paul's work include Neuroscience and Neuropharmacology Research (13 papers), Protein Tyrosine Phosphatases (13 papers) and Neuroinflammation and Neurodegeneration Mechanisms (11 papers). Surojit Paul is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Protein Tyrosine Phosphatases (13 papers) and Neuroinflammation and Neurodegeneration Mechanisms (11 papers). Surojit Paul collaborates with scholars based in United States, India and Canada. Surojit Paul's co-authors include Paul J. Lombroso, Eduardo Candelario‐Jalil, Angus C. Nairn, Ranjana Poddar, Paul Greengard, Michael W. Salter, Timothy D. Moran, Gunnar K. Gouras, Eric M. Snyder and Eun Young Choi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

In The Last Decade

Surojit Paul

38 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of NMDA receptor trafficking by amyloid-β

2005 1.3k citations Surojit Paul, Timothy D. Moran et al. Nature Neuroscience profile →
Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

2020 506 citations Surojit Paul, Eduardo Candelario‐Jalil Experimental Neurology profile →

Peers

Surojit Paul

CMN

PHYSI

NEURO

PHARM

Ling‐Qiang Zhu China

Nada M. Porter United States

Hoau-Yan Wang United States

Youming Lu China

Peter H. Reinhart United States

Thomas G. Ohm Germany

John J. LaFrancois United States

Carlos A. Saura Spain

Haakon B. Nygaard United States

Satyabrata Kar Canada

Ling‐Qiang Zhu China

Surojit Paul

1.0k ×0.5

CMN

2.4k ×1.3

1.2k ×1.0

PHYSI

672 ×0.8

NEURO

365 ×0.9

PHARM

Citations per year, relative to Surojit Paul Surojit Paul (= 1×) peers Ling‐Qiang Zhu

Countries citing papers authored by Surojit Paul

Since Specialization

Citations

This map shows the geographic impact of Surojit Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surojit Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surojit Paul more than expected).

Fields of papers citing papers by Surojit Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surojit Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surojit Paul. The network helps show where Surojit Paul may publish in the future.

Co-authorship network of co-authors of Surojit Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Surojit Paul. A scholar is included among the top collaborators of Surojit Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surojit Paul. Surojit Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paramasivam, Prabu, et al.. (2025). GluN2A–NMDAR mediated neuronal NFκB activation plays a key role in exacerbating ischemic brain injury under hyperhomocysteinemic conditions. Journal of Cerebral Blood Flow & Metabolism. 271678X251399012–271678X251399012.

Paul, Surojit, et al.. (2024). Homocysteine-induced sustained GluN2A NMDA receptor stimulation leads to mitochondrial ROS generation and neurotoxicity. Journal of Biological Chemistry. 300(5). 107253–107253. 12 indexed citations

Paramasivam, Prabu, Seong Won Choi, Ranjana Poddar, & Surojit Paul. (2024). Impairment of neuronal tyrosine phosphatase STEP worsens post-ischemic inflammation and brain injury under hypertensive condition. Journal of Neuroinflammation. 21(1). 271–271. 2 indexed citations

Candelario‐Jalil, Eduardo, et al.. (2022). Translating Animal Models of Ischemic Stroke to the Human Condition. Translational Stroke Research. 14(6). 842–853. 8 indexed citations

Farooqui, Mudassir, Asad Ikram, Sajid Suriya, et al.. (2020). Cytokine Registry In Stroke Patients (CRISP). Medicine. 99(28). e20921–e20921. 4 indexed citations

Paul, Surojit & Eduardo Candelario‐Jalil. (2020). Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Experimental Neurology. 335. 113518–113518. 506 indexed citations breakdown →

Candelario‐Jalil, Eduardo & Surojit Paul. (2020). Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective. Experimental Neurology. 335. 113494–113494. 50 indexed citations

Jindal, Ankur, Joshua W. Miller, Donald W. Jacobsen, et al.. (2019). Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors. Neurobiology of Disease. 127. 287–302. 25 indexed citations

Deb, Ishani, et al.. (2016). Aging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP. Neurobiology of Aging. 41. 25–38. 12 indexed citations

10.

Deb, Ishani, Ranjana Poddar, & Surojit Paul. (2010). Oxidative stress‐induced oligomerization inhibits the activity of the non‐receptor tyrosine phosphatase STEP₆₁. Journal of Neurochemistry. 116(6). 1097–1111. 23 indexed citations

11.

Poddar, Ranjana, et al.. (2010). NR2B‐NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell death. Journal of Neurochemistry. 115(6). 1350–1362. 47 indexed citations

12.

Paul, Surojit & John A. Connor. (2010). NR2B‐NMDA receptor‐mediated increases in intracellular Ca²⁺concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling. Journal of Neurochemistry. 114(4). 1107–1118. 75 indexed citations

13.

Venkitaramani, Deepa V., Surojit Paul, Yongfang Zhang, et al.. (2008). Knockout of STriatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation. Synapse. 63(1). 69–81. 70 indexed citations

14.

Venkitaramani, Deepa V., et al.. (2008). A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum. Biological Psychiatry. 65(8). 637–645. 24 indexed citations

15.

Braithwaite, Steven P., Surojit Paul, Angus C. Nairn, & Paul J. Lombroso. (2006). Synaptic plasticity: one STEP at a time. Trends in Neurosciences. 29(8). 452–458. 94 indexed citations

16.

Paul, Surojit, Peter Olausson, Deepa V. Venkitaramani, et al.. (2006). The Striatal-Enriched Protein Tyrosine Phosphatase Gates Long-Term Potentiation and Fear Memory in the Lateral Amygdala. Biological Psychiatry. 61(9). 1049–1061. 86 indexed citations

17.

Gharami, Kusumika, et al.. (2005). Thyroid hormone‐induced morphological differentiation and maturation of astrocytes involves activation of protein kinase A and ERK signalling pathway. European Journal of Neuroscience. 22(7). 1609–1617. 30 indexed citations

18.

Paul, Surojit, Angus C. Nairn, Ping Wang, & Paul J. Lombroso. (2002). NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nature Neuroscience. 6(1). 34–42. 271 indexed citations

19.

Morshed, Syed A., Salina Parveen, James F. Leckman, et al.. (2001). Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders. Biological Psychiatry. 50(8). 566–577. 98 indexed citations

20.

Paul, Surojit, Sumantra Das, & Pranab Kumar Sarkar. (1992). Effect of Hypothyroidism on Different Forms of Actin in Rat Cerebral Neuronal Cultures Studied by an Improved DNase I Inhibition Assay. Journal of Neurochemistry. 59(2). 701–707. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact